Search results
Blood Tests for Wegovy? Diagnostic Companies Target GLP-1s
Bloomberg· 3 hours agoCompanies that make diagnostic tests are targeting the ever-growing population of GLP-1 users. Have...
Zoetis beats profit estimates on strong demand for pet products
Reuters via AOL· 35 minutes agoZoetis deals with vaccines, medicines and diagnostic solutions for animals and manufactures products for livestock and fish, which it markets in more than 40 countries. The ...
Bruker Corp (BRKR) Q1 2024 Earnings: Mixed Results Amidst Strategic Acquisitions
GuruFocus.com via Yahoo Finance· 13 minutes agoOn May 2, 2024, Bruker Corp (NASDAQ:BRKR) released its 8-K filing, announcing the financial outcomes...
IDEXX Laboratories Inc (IDXX) (Q1 2024) Earnings Call Transcript Highlights: Key Financial ...
GuruFocus.com via Yahoo Finance· 6 hours agoOrganic Revenue Growth: 7% increase, with CAG Diagnostic recurring revenues also up 7%. Earnings Per Share (EPS): $2.81, up 10% as reported, 9% on a comparable basis. Gross ...
8 Early Signs of Autism in Infants & Toddlers That Every Parent Should Know
SheKnows via Yahoo News· 2 days agoAutism spectrum disorder rates continue to rise. The most recent data from the CDC, the most...
Earnings call: Envista Holdings reports modest Q1 growth, focuses on diagnostics By Investing.com
Investing.com· 4 hours agoThe company welcomed Paul Keel as its new President and CEO and outlined strategic priorities,...
Zomedica Strengthens Market Position with New Patents Issued for its TRUFORMA(R) Diagnostic Platform
The Joplin Globe· 2 hours agoANN ARBOR, MI / ACCESSWIRE / May 2, 2024 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostics ...
TIME100 Health: Ivan Cheung
Time via Yahoo News· 28 minutes ago“You always need an initial spark and I believe lecanemab provided the spark that will lead to more therapeutic options, morediagnostic options and more...
FDA approves Labcorp companion diagnostic for Pfizer gene therapy
Medical Device Network via Yahoo Finance· 2 days agoThe US Food and Drug Administration (FDA) has approved Labcorp’s nAbCyte Anti-AAVRh74var HB-FE assay...
Concert Expands Diagnostic Benefit Program to Manage Laboratory Testing for Health Plans
FOX 59 Indianapolis· 23 hours agoConcert has expanded its Diagnostic Benefit Program, formerly known as the Genetics Benefit Program, to provide payment and clinical policies and payment accuracy capabilities ...
